Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC EZM0414 | 2411748-50-8 | 99.1% | C22H29FN4O2 | 50 MG
SDP

Catalog No. 5000354853
Encompass_Preferred

EZM0414 is a potent, selective, and orally bioavailable inhibitor of SETD2. It is used for the research of relapsed or refractory multiple myeloma and diffuse large B-cell lymphoma.

  • Potent, selective, orally bioavailable inhibitor of SETD2
  • IC50 of 18 nM in SETD2 biochemical assay
  • IC50 of 34 nM in cellular assay
  • Inhibits proliferation of MM and DLBCL cell lines
  • Well-tolerated and inhibits tumor growth in xenograft models
  • Almost 100% oral bioavailability in rats and mice

Catalog No. 50-003-54853 Supplier Medchemexpress LLC Supplier No. HY14485850MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

EZM0414 is a potent, selective, and orally bioavailable inhibitor of SETD2. It is used for the research of relapsed or refractory multiple myeloma and diffuse large B-cell lymphoma.

  • Potent, selective, orally bioavailable inhibitor of SETD2
  • IC50 of 18 nM in SETD2 biochemical assay
  • IC50 of 34 nM in cellular assay
  • Inhibits proliferation of MM and DLBCL cell lines
  • Well-tolerated and inhibits tumor growth in xenograft models
  • Almost 100% oral bioavailability in rats and mice

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.